Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Foreign investors hope India dials back policy shocks after Modi win

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/24/2019 | 05:53am EDT
Indian Prime Minister Narendra Modi gestures as he is presented with a garland by Bharatiya Janata Party (BJP) leaders after the election results in New Delhi

NEW DELHI (Reuters) - Foreign companies in India have welcomed Prime Minister Narendra Modi's election victory for the political stability it brings, but now they need to see him soften a protectionist stance adopted in the past year.

Modi's pro-business image and India's youthful population have lured foreign investors, with U.S. firms such as Amazon.com, Walmart and Mastercard committing billions of dollars in investments and ramping up hiring.

India is also the biggest market by users for firms such as Facebook Inc, and its subsidiary, WhatsApp.

But from around 2017, critics say, the Hindu nationalist leader took a harder, protectionist line on sectors such as e-commerce and technology, crafting some policies that appeared to aim at whipping up patriotic fervor ahead of elections.

"I hope he's now back to wooing businesses," said Prasanto Roy, a technology policy analyst based in New Delhi, who advises global tech firms.

"Global firms remain deeply concerned about the lack of policy stability or predictability, this has sent a worrying message to global investors."

India stuck to its policies despite protests and aggressive lobbying by the United States government, U.S.-India trade bodies and companies themselves.

SMALL HURDLES

Modi was set to hold talks on Friday to form a new cabinet after election panel data showed his Bharatiya Janata Party had won 302 of the 542 seats at stake and was leading in one more, up from the 282 it won in 2014.

After Modi's win, about a dozen officials of foreign companies in India and their advisers told Reuters they hoped he would ease his stance and dilute some of the policies.

Other investors hope the government will avoid sudden policy changes on investment and regulation that catch them off guard and prove very costly, urging instead industry-wide consultation that permits time to prepare.

Protectionism concerns "are small hurdles you have to go through", however, said Prem Watsa, the chairman of Canadian diversified investment firm Fairfax Financial, which has investments of $5 billion in India.

"There will be more business-friendly policies and more private enterprise coming into India," he told Reuters in an interview.

TECH, HEALTHCARE AND BEYOND

Among the firms looking for more friendly steps are global payments companies that had benefited since 2016 from Modi's push for electronic payments instead of cash.

Last year, however, firms such as Mastercard and Visa were asked to store more of their data in India, to allow "unfettered supervisory access", a change that prompted WhatsApp to delay plans for a payments service.

Modi's government has also drafted a law to clamp similar stringent data norms on the entire sector.

But abrupt changes to rules on foreign investment in e-commerce stoked alarm at firms such as Amazon, which saw India operations disrupted briefly in February, and Walmart, just months after it invested $16 billion in India's Flipkart.

Policy changes also hurt foreign players in the $5-billion medical device industry, such as Abbott Laboratories, Boston Scientific and Johnson & Johnson, following 2017 price caps on products such as heart stents and knee implants.

Modi's government said the move aimed to help poor patients and curb profiteering, but the U.S. government and lobby groups said it harmed innovation, profits and investment plans.

"If foreign companies see their future in this country on a long-term basis...they will have to look at the interests of the people," Ashwani Mahajan, an official of a nationalist group that pushed for some of the measures, told Reuters.

That view was echoed this week by two policymakers who said government policies will focus on strengthening India's own companies, while providing foreign players with adequate opportunities for growth.

Such comments worry foreign executives who fear Modi is not about to change his protectionist stance in a hurry, with one offical of a U.S. tech firm saying, "I'd rather be more worried than be optimistic."

(Reporting by Aditya Kalra and Aditi Shah; Additional reporting by Euan Rocha and Manoj Kumar; Editing by Martin Howell and Clarence Fernandez)

By Aditya Kalra and Aditi Shah

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -0.21% 82.05 Delayed Quote.13.44%
AMAZON.COM 0.88% 1886.03 Delayed Quote.24.48%
BOSTON SCIENTIFIC CORPORATION 0.64% 40.68 Delayed Quote.14.37%
FACEBOOK 4.24% 189.01 Delayed Quote.44.18%
FAIRFAX FINANCIAL HOLDINGS LTD 0.88% 638.89 Delayed Quote.5.38%
MASTERCARD -0.35% 259.2 Delayed Quote.37.40%
WAL-MART STORES 0.08% 109.16 Delayed Quote.17.19%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBOTT LABORATORIES
06/17ABBOTT LABORATORIES : CARE, Abbott and the Abbott Fund Launch Partnership to Add..
PR
06/17ABBOTT LABORATORIES : Launches Rapid Point-of-Care HbA1c Test to Aid in Diabetes..
DJ
06/17ABBOTT LABORATORIES : Launches First-ever Rapid Point-of-Care HbA1c Test to Aid ..
PU
06/14ABBOTT : Declares 382ⁿᵈ Consecutive Quarterly Dividend
PR
06/14ABBOTT LABORATORIES : - new survey shows millennials can help avoid blood shorta..
AQ
06/10ABBOTT LABORATORIES : New data show use of abbott's freestyle libre system signi..
AQ
06/10ADA : Real-world data show lower A1c levels with Abbott's FreeStyle Libre CGM in..
AQ
05/29Johnson & Johnson Weighs on Pharmaceutical ETFs
DJ
05/24Foreign investors hope India dials back policy shocks after Modi win
RE
05/22ABBOTT LABORATORIES : - triluminate study shows treatment with 's first-of-its-k..
AQ
More news
Financials ($)
Sales 2019 31 988 M
EBIT 2019 7 175 M
Net income 2019 3 839 M
Debt 2019 11 817 M
Yield 2019 1,52%
P/E ratio 2019 41,26
P/E ratio 2020 34,23
EV / Sales 2019 4,82x
EV / Sales 2020 4,43x
Capitalization 142 B
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 83,2 $
Spread / Average Target 3,1%
EPS Revisions
Managers
NameTitle
Miles D. White Chairman & Chief Executive Officer
Robert B. Ford President & Chief Operating Officer
Brian Bernard Yoor Chief Financial Officer & Executive VP-Finance
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES13.44%133 566
MASIMO CORPORATION32.12%6 891
ASAHI INTECC CO., LTD.17.29%6 652
NOVOCURE LTD73.36%5 033
PENUMBRA INC36.62%5 013
GETINGE83.85%3 500